Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Frequently asked questions
What sector does Roche Holding AG (ROGN) operate in?
Roche Holding AG belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Roche Holding AG (ROGN) current stock price?
As of the latest data, Roche Holding AG stock price is MX$7,050.00, with a previous close of MX$7,050.00.
What is Roche Holding AG (ROGN) current market capitalization?
Roche Holding AG market cap is approximately 4.86 trillion.
What is Roche Holding AG (ROGN) Earnings Per Share (EPS)?
The trailing EPS is MX$360.82.
What is Roche Holding AG (ROGN) Price-to-Earnings (P/E) ratio?
Roche Holding AG current P/E ratio is 19.54.
Does Roche Holding AG (ROGN) pay dividends?
No. Roche Holding AG does not pay a dividend.
What is Roche Holding AG (ROGN) beta (volatility) score?
Roche Holding AG has a beta of 0.211, indicating lower volatility than the overall market.